HomeNewsBusiness‘This is insanity’: Startups end year in a deal frenzy
Trending Topics

‘This is insanity’: Startups end year in a deal frenzy

Now, as the new reality of remote work, school, shopping and socializing supercharges the adoption of tech products and services, sentiment has flipped even further — to a frenzy of deal-making.

December 07, 2020 / 23:02 IST
Story continues below Advertisement
At the onset of the pandemic, warnings of startup doom abounded. Those largely faded after the initial shock of the coronavirus wore off. | Representative Image.
At the onset of the pandemic, warnings of startup doom abounded. Those largely faded after the initial shock of the coronavirus wore off. | Representative Image.

Hopin, a virtual events startup in London, had seven employees and was valued at $38 million at the beginning of the year. Johnny Boufarhat, the company’s chief executive, wasn’t planning on raising more money.

But as the pandemic spread and more people held virtual events, Hopin’s business took off. Unsolicited offers from investors started pouring in. “It’s like a drumbeat,” Boufarhat said. “That’s become the new way for investors to tempt founders.”

Story continues below Advertisement

In June, Hopin raised a fresh $40 million from venture capital firms such as Accel and IVP. Last month, without even building a formal presentation, the company garnered a further $125 million, valuing it at $2.1 billion — a 77-fold increase from a year ago.

Facebook nears deal to buy customer-service startup Kustomer: Report

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show